Aminorex

Identification

Generic Name
Aminorex
DrugBank Accession Number
DB01490
Background

Aminorex is an amphetamine-like anorectic agent. It may cause pulmonary hypertension.

Type
Small Molecule
Groups
Experimental, Illicit
Structure
Weight
Average: 162.1885
Monoisotopic: 162.079312952
Chemical Formula
C9H10N2O
Synonyms
  • Aminorex
  • Aminorexum
External IDs
  • McN 742
  • McN-742

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
International/Other Brands
Apiquel

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Not Available
Direct Parent
Benzene and substituted derivatives
Alternative Parents
Oxazolines / Isoureas / Propargyl-type 1,3-dipolar organic compounds / Oxacyclic compounds / Carboximidamides / Azacyclic compounds / Organopnictogen compounds / Organooxygen compounds / Hydrocarbon derivatives
Substituents
Aromatic heteromonocyclic compound / Azacycle / Carboximidamide / Hydrocarbon derivative / Isourea / Monocyclic benzene moiety / Organic 1,3-dipolar compound / Organic nitrogen compound / Organic oxygen compound / Organoheterocyclic compound
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
2SH16612I9
CAS number
2207-50-3
InChI Key
SYAKTDIEAPMBAL-UHFFFAOYSA-N
InChI
InChI=1S/C9H10N2O/c10-9-11-6-8(12-9)7-4-2-1-3-5-7/h1-5,8H,6H2,(H2,10,11)
IUPAC Name
5-phenyl-4,5-dihydro-1,3-oxazol-2-amine
SMILES
NC1=NCC(O1)C1=CC=CC=C1

References

Synthesis Reference
US3161650
General References
Not Available
KEGG Drug
D02909
PubChem Compound
16630
PubChem Substance
46507089
ChemSpider
15767
BindingDB
85705
ChEBI
134792
ChEMBL
CHEMBL106258
Wikipedia
Aminorex

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)137 °CPhysProp
Predicted Properties
PropertyValueSource
Water Solubility0.792 mg/mLALOGPS
logP1.16ALOGPS
logP1.46Chemaxon
logS-2.3ALOGPS
pKa (Strongest Acidic)19.48Chemaxon
pKa (Strongest Basic)7.49Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area47.61 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity45.75 m3·mol-1Chemaxon
Polarizability16.97 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+1.0
Blood Brain Barrier+0.9903
Caco-2 permeable-0.5458
P-glycoprotein substrateNon-substrate0.7834
P-glycoprotein inhibitor INon-inhibitor0.9726
P-glycoprotein inhibitor IINon-inhibitor0.9295
Renal organic cation transporterNon-inhibitor0.7325
CYP450 2C9 substrateNon-substrate0.8176
CYP450 2D6 substrateNon-substrate0.7575
CYP450 3A4 substrateNon-substrate0.6674
CYP450 1A2 substrateInhibitor0.5315
CYP450 2C9 inhibitorNon-inhibitor0.6468
CYP450 2D6 inhibitorNon-inhibitor0.7673
CYP450 2C19 inhibitorNon-inhibitor0.782
CYP450 3A4 inhibitorNon-inhibitor0.9578
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.762
Ames testNon AMES toxic0.5633
CarcinogenicityNon-carcinogens0.8851
BiodegradationNot ready biodegradable0.9556
Rat acute toxicity2.5964 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.941
hERG inhibition (predictor II)Non-inhibitor0.9185
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-00mo-7900000000-f9eef0200f54882247ea
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-03di-0900000000-a6b0226fbb3e98d32a86
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-03di-1900000000-a2937c90366b1536ed8f
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0w29-2900000000-2e16447c06202c1b57b5
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9100000000-f865dbb88af1ce411309
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0fb9-9400000000-48cdf201758b735c9981
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9100000000-944b9964b8eb3bcd5e78
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-133.25514
predicted
DeepCCS 1.0 (2019)
[M+H]+136.11157
predicted
DeepCCS 1.0 (2019)
[M+Na]+145.33456
predicted
DeepCCS 1.0 (2019)

Drug created at July 31, 2007 13:09 / Updated at February 21, 2021 18:51